Holmusk’s Post

View organization page for Holmusk, graphic

25,857 followers

Proud of the Holmusk team that brought this impactful collaboration to life!

Holmusk is changing the way we treat opioid addiction. In a recent peer-reviewed paper in the journal Addiction, researchers from Stanford University used Holmusk data to predict whether patients will continue their treatment with buprenorphine-naloxone, a medication used for opioid addiction, for at least six months. This research, funded by NIH and Gordon and Betty Moore Foundation, used Holmusk data to develop machine learning models that predicted treatment continuation. It achieved results comparable to predictions made by addiction medicine specialists. Holmusk’s NeuroBlu uses high-quality data generated from actual patient interactions. This kind of data is creating groundbreaking results in mental health, addiction, and beyond. That’s how Holmusk is charting the future of treatment.

To view or add a comment, sign in

Explore topics